Zavřít

CZ - CS


Please select a country and, if applicable, a language.

Samoléčba je důležitým pilířem zdravotnictví

… a stejně jako léčba předepsaná lékařem by měla být prováděna na základě dostupných důkazů. Evidence for Self-Medication (EfSM) (důkazy pro samoléčbu) předkládá ucelené zprávy příslušných studií zkoumajících volně prodejné léčivé přípravky a účinné látky, aby mohli lékárníci a ostatní zdravotničtí odborníci co možná nejlépe – a s doložením důkazů – radit ohledně samoléčby. 

 

Všechny články EfSM prošly recenzním řízením. Jsou k dispozici v němčině a angličtině a mnohé z nich i v řadě dalších jazyků.

Omeprazole vs. Poliprotect®

Clinical trial demonstrating non-inferiority of Poliprotect for heartburn and epigastric pain in patients without erosive esophagitis


A randomised, controlled, multicentre, double-blind and double-masked study confirmed the efficacy of Poliprotect®, a molecular complex of natural ingredients designed for the protection of the gastroesophageal mucosa, contained in the medicinal product NeoBianacid®. Poliprotect was non-inferior to the standard dose of omeprazole (20 mg/day) in the treatment of symptoms of non-erosive gastroe ...

K článku
Autor: Frederick HerbstEFSM: 2023;3:230055DOI: 10.52778/efsm.23.0055Datum: 17.12.2023

Bioceramic materials emitting infrared radiation for musculoskeletal pain relief


Musculoskeletal (MSK) disorders are the leading cause of chronic pain, physical, functional impairment and loss of quality of life. About one in three people worldwide is suffering from MSK pain. The biological effects of bioceramic materials as Infrared-C emitters on body tissues and their benefits to the self-management of MSK disorders, are the subject of current interest.

K článku
Autor: Bill Giannakopoulos, PharmD, Mohamed Amessou, PhD, MBA a Eva Koscova, MD, PhD, MBA, CVTI SREFSM: 2023;3:230049DOI: 10.52778/efsm.23.0049Datum: 17.12.2023

Promoted to the highest evidence class: meta-analysis supports the evidence for EA 575® in treating…


In self-limiting diseases such as acute respiratory infections, patients primarily expect relief of their symptoms, the aim being to reduce suffering and thus improve their quality of life. The results of a meta-analysis of two studies conducted in line with recognized scientific standards show that the positive effects of the dry ivy leaf extract EA  575® are visible and subjectively noticea ...

K článku
Autor: Dr Lukas Uebbing a Dr Simon BraunEFSM: 2023;3:230041DOI: 10.52778/efsm.23.0041Datum: 17.10.2023

Bacillus clausii's protective and restorative mechanisms in PPI-induced gut imbalance using SHIME …


Long-term use of proton pump inhibitors (PPI) may lead to gut flora imbalance, which may be restored using probiotics. The study demonstrated the probiotic effects of B. clausii on gut microbiota health following PPI-induced dysbiosis using the Simulator of the Human Intestinal Microbial Ecosystem® (SHIME) model. The probiotic specifically improved microbial diversity and butyrate levels, among ot ...

K článku
Autor: Zefferino Righetto, Daniel Marquez a Marcos Perez III, MDEFSM: 2023;3:230034DOI: 10.52778/efsm.23.0034Datum: 05.10.2023

Perceived effectiveness and increased quality of life after Macrogol 4000 use in patients with …


With a prevalence of 14 – 30% in Spain, constipation impacts quality of life (QoL) and general well-being in the affected population. A survey conducted through Spanish pharmacies among 100 consumers who purchased Macrogol  4000 to alleviate constipation symptoms, evaluated their perception on QoL improvement and effectiveness on constipation symptoms. After 14 days of treatment, a ...

K článku
Autor: Georgina Logusso, Nuno Correia, Alexia Aran a Maria MilitaoEFSM: 2023;3:230030DOI: 10.52778/efsm.23.0030Datum: 25.09.2023

Novinky EfSM


Zaregistrujte se k odběru našich novinek. Budete mít informace o nejnovějších publikacích EfSM.

Zaregistrovat zde

Zajímavý článek

Fexofenadine in children with allergic rhinitis


Oral antihistamines are first-line treatments for children with allergic rhinitis. A recent review evaluated second-generation antihistamines in comparison to first-generation antihistamines.

K článku